CDK4/6 Inhibitors in the Treatment of Advanced ER/PR-Positive, HER2-Negative Breast Cancer: An Updated Single-Center Analysis of Real-World Data.
Overview & Synopsis
Open access biomedical research article published in Breast Care (Basel).
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | CDK4/6 Inhibitors in the Treatment of Advanced ER/PR-Positive, HER2-Negative Breast Cancer: An Updated Single-Center Analysis of Real-World Data. |
|---|---|
| Author / Organization | Rambow AC, Schröder TJ, Wagenpfeil G, Jansen P, Le HD, Rogmans C, Tribian N, Maass N, van Mackelenbergh M |
| Subject & Discipline | Breast Care (Basel) |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-50496 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |